Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 71Observational 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Breast Neoplasms 31Stomach Neoplasms 4Neoplasms 4Cardiotoxicity 4Neoplasm Metastasis 3Brain Neoplasms 2Neurotoxicity Syndromes 1Neoplasms, Second Primary 1Neoplasm, Residual 1HER2-positive Breast Cancer 1HER2+ Breast Cancer 1Feasibility 1Fatigue 1Breast Cancer Organoids 1

Interventions

Gastrectomy 13Observation 12Gastroscopy 11Drug Therapy 9Surveys and Questionnaires 8Surgical Procedures, Operative 8Endoscopic Mucosal Resection 8Paclitaxel 6Immune Checkpoint Inhibitors 6Blood Specimen Collection 6Tomography, X-Ray Computed 5Oxaliplatin 5Trastuzumab 4Ramucirumab 4Irinotecan 4Immunotherapy 4Hyperthermic Intraperitoneal Chemotherapy 4Cisplatin 4Biopsy 4tislelizumab 3S 1 (combination) 3Robotic Surgical Procedures 3Radiotherapy 3Positron Emission Tomography Computed Tomography 3Nivolumab 3Neoadjuvant Therapy 3Laparoscopy 3Interviews as Topic 3Capecitabine 3taxane 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Stomach Neoplasms × Trastuzumab × Clear all
NCT07009600 2025-06-06

Conversion Surgery After Target Therapy or Immunotherapy in Stage IV Gastric Cancer

Samsung Medical Center

Completed
124 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01839500 2018-03-29

EVIDENCE

Hoffmann-La Roche

Completed
1,600 enrolled
Gastrointestinal

Stomach Neoplasms

NCT03024450 2017-01-24

Trastuzumab Based Therapy in HER2 Positive AGC

Shanghai Zhongshan Hospital

Completed
98 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02731313 2016-10-28

Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma

Hoffmann-La Roche

Completed
420 enrolled 8 charts
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡